Samsung to pour in $500 million for a new manufacturing unit in India
By Akshay Kedari  Date: 2020-01-20

Samsung to pour in $500 million for a new manufacturing unit in India

One of the leading smartphone brands, Samsung Electronics is planning to invest $500 million in its Indian business by building a display manufacturing unit in the outskirts of New Delhi. Along with making displays, the new facility would work on manufacturing a wide range of other electronic gadgets as well.

Reportedly, Samsung has revealed that it has secured a portion of land for its new plant from its standing unit in Noida. Earlier in 2018, Samsung had inaugurated its Noida plant, claiming it to be the world’s largest mobile manufacturing unit, built with a commitment towards investing roughly around $700 million.

As for the new facility, it would allow Samsung to further expand its capacity to manufacture components for smartphones locally and would endow them with a variety of tax benefits coming from New Delhi. These benefits would help Samsung get a competitive edge over Xiaomi, a Chinese smartphone firm that dethroned Samsung in early 2018’s.

According to reports, Samsung is currently the second-biggest smartphone company in India, a market which holds around 500 million smartphone users. However, the company is facing tough competition from other Chinese firm like Realme, which is projected to surpass the South Korean smartphone company in the coming years.

In other news, Samsung is planning to expand its European consumer base by launching its flagship mid variant mobile, Samsung Galaxy A51. As per credible sources, the Galaxy A51 would be starting at €370 and would steadily go up for high memory storage variants.

For Samsung’s French consumers, the smartphone would be available in two variant 4/64 GB and 6/128 GB on Amazon along with other retailers and would be positioned at a price point of €340 and €410. Meanwhile, its Dutch customers could visit Belsimpel and choose the best deal with or without a carrier.

Source Credit: https://techcrunch.com/2020/01/19/samsung-invests-500m-to-set-up-a-smartphone-display-plant-in-india/

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...